期刊
LEUKEMIA & LYMPHOMA
卷 55, 期 12, 页码 2835-2841出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2014.893309
关键词
POEMS syndrome; depression; PHQ-9
资金
- Capital Health Research and Development of Special [2011-4001-03]
- Beijing Municipal Science & Technology Commission [Z111107058811019]
- Peking Union Medical College New Star
- National Public Health Grand Research Foundation [201202017]
This prospective study delineated the prevalence and risk factors for clinical depression in patients with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes). Using a PHQ-9 (Patient Health Questionnaire scale-9, which evaluates the severity of depressive symptoms) score cut-off >= 10, the prevalence of pretreatment depression was 38.0%. Based on multivariate logistic regression, higher ONLS (Overall Neuropathy Limitation Scale, which assesses the severity of neuropathy) upper limb scores (hazard ratio [HR] 1.75; 95% confidence interval [CI] 1.09-2.81; p = 0.02) and ascites (HR 4.30; 95% CI 1.03-17.9; p = 0.04) were significant and independent predictors for depression. The incidence of post-treatment depression was 1.53% by the end of follow-up, while no patients received antidepressants. A preliminary logistic regression suggested depression to be a risk factor for early death (within 3 months after diagnosis) (HR 9.77; 95% CI, 1.08-88.9; p = 0.04).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据